Degussa Aktiengesellschaft

Evonik Degussa Gmbh

Dieter Greissinger

Walter Pfefferle

Michael Binder

Klaus Huthmacher

Georg Thierbach

Brigitte Bathe

Joern Kalinowski

Alfred Puehler

Christian Rueckert

Bettina Moeckel

Matthias Moll

Alexander Moeller

Mike Farwick

Winfried Heimbeck

Wolfgang Polzer

Heinz Friedrich

Martin Koerfer

Natalie Schischka

Herbert Tanner

Hermann Lotter

Franz-Ludwig Dahm

Wolfram Binder

Jennifer Brehme

Ulrich Hertz

Wolfgang Hohn

Nongyuan Shi-Muenzenberg

Wolfgang Moese

Hans Albrecht Hasseberg

Heidermarie Kniesel

Active compound formulations for animal nutrition of amino acids, vitamins, enzymes and pigments, which are suitable for providing the active compounds in protected form for the nutrition of stock animals, in particular ruminants, and a process for the preparation of these protected active compound formulations.

Protected active compound formulations of amino acids and process for their preparation

An isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of

Nucleotide sequence which code for the metH gene

Isolated polynucleotide from Corynebacterium encoding a homocysteine methyltransferase

Nucleotide sequences from coryneform bacteria which code for the cysD, cysN, cysK, cysE and cysH genes and a process for the fermentative preparation of amino acids using bacteria in which the genes mentioned are enhanced, a process for the fermentative preparation of L-amino acids using coryneform bacteria in which at least the cysD gene, the cysN gene, the cysK gene, the cysE gene and/or the cysH gene is present in enhanced form, and the use of polynucleotides which contain the sequences according to the invention as hybridization probes and a process for the preparation of an L-methionine-containing animal feedstuffs additive from fermentation broths.

Nucleotide sequences which code for the cysD, cysN, cysK, cysE and cysH genes

The present invention relates to isolated polynucleotides from encoding proteins of the transcription activator (MetR) and O-succinylhomoserine sulfhydrylase (MetZ). The invention also relates to producing L-amino acids, particularly methionine, in coryneform cells having attenuated metR and metZ genes.

Nucleotide sequences encoding o-succinylhomoserine sulfhydrylase

The present invention relates to isolated polynucleotides which encode proteins with O-acetylhomoserine sulfhydrylase, vectors and cells containing the polynucleotides as well as methods of preparing L-amino acids.

Nucleotide sequences which code for the metY gene

Nucleotide sequences which code for the sahH gene

A composition including at least one of D-pantothenic acid and a salt of D-panthothenic acid, greater than 50 percent of non-biomass constituents of a D-pantothenic fermentation liquor, and 0 to 100% of the biomass from D-pantothenic fermentation liquor wherein composition is a solid, pourable composition in the form of particles.

Pourable feed additives containing D-pantothenic acid and/or salts thereof, and process for their preparation

An animal feed additive comprising stable pellets is produced by pelletizing from a fermentation broth containing an animal feed additive with at least 33% by weight of the fermentation products present. The pellets can be produced particularly effectively by pelletizing providing they are built up from at least 30% by weight of fine particles of which at least 70% by weight are smaller than 100 .mu.m in size. The biomass may be completely present, partly present or not present at all in the pellets.

Animal feed additive based on fermentation broth, a process for its

A dosage form for administering physiologically active substances to animals, especially ruminant animals. The dosage unit includes a core which contains the active substance and a coating. The coating has selected areas which are thinner than the average thickness of the coating and/or areas which are predetermined rupture sites. These thin areas or predetermined rupture sites are constructed and arranged so as to detach and/or rupture under the conditions which are present after oral administration of the dosage form. As a result, the delayed release of the physiologically-active substance is accelerated. For example, the coating may be formulated to not be affected in the first stomach of a ruminant but to rapidly disintegrate in the animal's second stomach.

Active-substance preparation for oral administration, especially to

Growing community of inventors

Niddatal, Germany

Dieter Greissinger